The Speicher
laboratory uses proteomics, metabolomics, computational methods, and biophysical approaches to characterize the roles of normal and mutant proteins in cancers and other human diseases.
Not exact matches
The research team identified over one thousand such proteins by
using innovative
proteomic methods, developed by Professor Matthias Hentze and colleagues from EMBL, which is Europe's flagship
laboratory for the life sciences.
His
laboratory uses a multidisciplinary approach encompassing systems biology, molecular pharmacology, biochemistry /
proteomics, cell and structural biology, and computation / bioinformatics.
His
laboratory is also keenly interested in utilizing high - throughput
proteomic approaches for the discovery of biomarkers for diseases such as cancer and exploring the
use of
proteomic and metabolomic technology for the routine interrogation of clinical samples.
He was promoted to Director of
Proteomics, where he designed and implemented a number of technologies currently used in many proteomics laboratories across
Proteomics, where he designed and implemented a number of technologies currently
used in many
proteomics laboratories across
proteomics laboratories across the world.
His
laboratory uses integrated genomics and
proteomics as well as computational methods to elucidate disease mechanisms and discover biomarkers for non-communicable and infectious diseases.
Results: Scientists at Pacific Northwest National
Laboratory (PNNL) have reported the first systematic investigation
using global
proteomics to identify changes in the abundance of bacterial proteins associated with macrophage colonization and a new protein that helps the bacterium to survive inside macrophages.
Methods: The researchers
used mass spectrometry - based
proteomics at the U.S. Department of Energy's Environmental Molecular Science
Laboratory, a national scientific user facility at PNNL, on platelets from healthy and type 2 diabetics collected at the University of Rochester Blood Bank.
Using state - of - the - art
proteomics and associated computational methods, the Speicher
laboratory is investigating protein changes associated with ovarian cancer, melanoma, cardiac injury resulting from breast cancer therapies, ectopic pregnancy, red cell diseases, and other clinical disorders.
My
laboratory also conducts fundamental research
using genetics, biochemistry, cell biology and
proteomics to define mechanisms of ECM assembly and turnover and their effects on cell behavior.